DH / Definitive Healthcare Corp (DH) CEO Robert Musslewhite on Q2 2022 Results - Earnings Call Transcript

Definitive Healthcare Corp. (DH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings more_horizontal

DH Q2 results were solid, with revenue in line and adjusted EBITDA slightly ahead. The company's near-term outlook is uncertain due to macroeconomic f more_horizontal

Definitive Healthcare Corp. (NASDAQ:DH ) Q2 2023 Results Conference Call August 14, 2023 5:00 PM ET Company Participants Matt Ruderman - Chief Legal O more_horizontal

Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how NEOG, PDCO and DH are poised more_horizontal

Definitive Healthcare Corp. (DH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients more_horizontal

Definitive Healthcare Corp. is a leader in the healthcare commercial intelligence market, providing comprehensive data and insights for the industry w more_horizontal

Definitive Healthcare Corp. (NASDAQ:DH ) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants Matt Ruderman – Chief Legal Of more_horizontal

Similar to identifying stocks with growth potential, pinpointing toxic stocks and discarding them at the right time is the key to avoid losses. CSGP, more_horizontal